SPECIFIC FEATURES OF CATARACT SURGERY IN DIABETIC PATIENTS AND POSTOPERATIVE COMPLICATIONS
Keywords:
Keywords: diabetes mellitus; diabetic cataract; phacoemulsification; diabetic retinopathy; diabetic macular edema; pseudophakic cystoid macular edema; anti-VEGF; endophthalmitis; postoperative complications.Abstract
Diabetes mellitus (DM) changes the crystalline lens, ocular surface, cornea, iris, retina and wound-healing response. Cataract develops earlier and more often in people with diabetes, and the global number of adults with diabetes reached 589 million in 2024 [1]. Although modern phacoemulsification usually gives meaningful visual benefit, diabetic patients have a distinct perioperative risk profile, particularly when diabetic retinopathy (DR) or diabetic macular edema (DME) is present.
References
1.International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025. https://diabetesatlas.org
2.Becker C, Schneider C, Aballéa S, et al. Cataract in patients with diabetes mellitus—incidence rates in the UK and risk factors. Eye (Lond). 2018;32(6):1028-1035. doi:10.1038/s41433-017-0003-1. https://www.nature.com/articles/s41433-017-0003-1
3.Chu CJ, Johnston RL, Buscombe C, Sallam AB, Mohamed Q, Yang YC. Risk factors and incidence of macular edema after cataract surgery: a database study of 81,984 eyes. Ophthalmology. 2016;123(2):316-323. doi:10.1016/j.ophtha.2015.10.001. PMID:26681390.
4.Lee SH, Tseng BY, Wu MC, Wang JH, Chiu CJ. Incidence and progression of diabetic retinopathy after cataract surgery: a systematic review and meta-analysis. Am J Ophthalmol. 2025;269:105-115. doi:10.1016/j.ajo.2024.08.017. PMID:39179126.
5.Laursen SB, Erichsen JH, Holm LM, Kessel L. Prevention of macular edema in patients with diabetes after cataract surgery. J Cataract Refract Surg. 2019;45(6):854-869. doi:10.1016/j.jcrs.2019.04.025. PMID:31146934.
6.GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health. 2021;9(2):e144-e160. doi:10.1016/S2214-109X(20)30489-7. PMID:33275949.
7.Pollreisz A, Schmidt-Erfurth U. Diabetic cataract—pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751. doi:10.1155/2010/608751.
8.Kiziltoprak H, Tekin K, Inanc M, Goker YS. Cataract in diabetes mellitus. World J Diabetes. 2019;10(3):140-153. doi:10.4239/wjd.v10.i3.140.
9.Zarei-Ghanavati S, Hadi Y, Habibi A, Ashraf Khorasani M, Yoo SH. Cataract and diabetes: review of the literature. J Cataract Refract Surg. 2024;50(12):1275-1283. doi:10.1097/j.jcrs.0000000000001547. PMID:39254426.
10.Kelkar A, Kelkar J, Mehta H, Amoaku W. Cataract surgery in diabetes mellitus: a systematic review. Indian J Ophthalmol. 2018;66(10):1401-1410. doi:10.4103/ijo.IJO_1158_17. PMID:30249823.
11.Zhang R, Dong L, Yang Q, Liu Y, Li H, Zhou W, et al. Prophylactic interventions for preventing macular edema after cataract surgery in patients with diabetes: a Bayesian network meta-analysis of randomized controlled trials. EClinicalMedicine. 2022;49:101463. doi:10.1016/j.eclinm.2022.101463. PMID:35747191.
12.Wu J, Zhou Y, Zhen F, Wang S, Li Q, Dong S. Management after cataract surgery for patients with diabetic retinopathy: a systematic review and meta-analysis. Int Ophthalmol. 2024;44(1):166. doi:10.1007/s10792-024-02981-6. PMID:38557801.
13.Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128(11):1580-1591. doi:10.1016/j.ophtha.2021.04.027. PMID:33940045.
14.Ljubimov AV. Diabetic complications in the cornea. Vision Res. 2017;139:138-152. doi:10.1016/j.visres.2017.03.002. PMID:28404521.
15.Grzybowski A, Kanclerz P, Huerva V, Ascaso FJ, Tuuminen R. Diabetes and phacoemulsification cataract surgery: difficulties, risks and potential complications. J Clin Med. 2019;8(5):716. doi:10.3390/jcm8050716. PMID:31137510.
16.Chen Y, Fu Y, Li L, Li W, Zhang Y, Liu Y, Zhang Q, Ke M. OCT-based quantitative comparison of full-thickness healing of corneal incisions in cataract surgery between diabetic and nondiabetic patients. Cornea. 2026. doi:10.1097/ICO.0000000000004216. PMID:42312563.
17.Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682. doi:10.1016/S0161-6420(03)00475-5. PMID:13129861.
18.Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, Ying GS. Diabetic Retinopathy Preferred Practice Pattern®. Ophthalmology. 2020;127(1):P66-P145. doi:10.1016/j.ophtha.2019.09.025. https://www.aao.org/education/preferred-practice-pattern/diabetic-retinopathy-ppp
19.American Diabetes Association Professional Practice Committee. 12. Retinopathy, neuropathy, and foot care: Standards of Care in Diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S252-S265. doi:10.2337/dc25-S012. https://diabetesjournals.org/care/article/48/Supplement_1/S252/157565/12-Retinopathy-Neuropathy-and-Foot-Care-Standards
20.European Society of Cataract and Refractive Surgeons (ESCRS). ESCRS Recommendations for Cataract Surgery. Evidence-based guideline; accessed 18 October 2026. https://www.escrs.org/escrs-recommendations-for-cataract-surgery
21.Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW; ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33(6):978-988. doi:10.1016/j.jcrs.2007.02.032.
22.Hayashi K, Hayashi H, Nakao F, Hayashi F. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. Am J Ophthalmol. 2002;134(1):10-16. doi:10.1016/S0002-9394(02)01461-5.
23.Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology. 2007;114(5):881-889. doi:10.1016/j.ophtha.2006.08.053.
24.Diabetic Retinopathy Clinical Research Network Authors/Writing Committee; Baker CW, Almukhtar T, Bressler NM, Glassman AR, Grover S, Kim SJ, et al. Macular edema after cataract surgery in eyes without preoperative central-involved diabetic macular edema. JAMA Ophthalmol. 2013;131(7):870-879. doi:10.1001/jamaophthalmol.2013.2313. PMID:23599174.
25.Wielders LHP, Schouten JSAG, Winkens B, et al; ESCRS PREMED Study Group. Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED Study Report 2. J Cataract Refract Surg. 2018;44(7):836-847. PMID:30055692.
26.Squirrell D, Bhola R, Bush J, Winder S, Talbot JF. A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol. 2002;86(5):565-571. doi:10.1136/bjo.86.5.565.
27.Loya A, Hussain ZS, Muayad J, Chauhan MZ, Soliman MK, Sallam AB. Risk of progression of nonproliferative to proliferative diabetic retinopathy after cataract surgery. Ophthalmology. 2025;132(7):817-822. doi:10.1016/j.ophtha.2025.02.006. PMID:39956206.